Literature DB >> 19596742

Early histological changes in the kidney of people with morbid obesity.

Dimitrios S Goumenos1, Bisher Kawar, Meguid El Nahas, Sara Conti, Bart Wagner, Charalambos Spyropoulos, John G Vlachojannis, Ariela Benigni, Fotios Kalfarentzos.   

Abstract

BACKGROUND: Morbid obesity represents a major health problem with increasing incidence worldwide. The clinical manifestation of renal involvement in obesity is proteinuria, and the histological feature is glomerulomegaly with or without focal and segmental glomerulosclerosis (FSGS). In this study, we have investigated the very early histological changes in kidneys of people with morbid obesity and no proteinuria. Patients and methods. Eighteen patients with body mass index (BMI) >50 kg/m(2) who underwent a variant of biliopancreatic diversion with Roux-en-Y reconstruction (BPD-RYGBP) and consented to undergo a renal biopsy during the surgical procedure were included in the study. The estimation of early histological changes was performed on light (n = 18) and electron microscopy (n = 13).
RESULTS: The mean glomerular cross-sectional area was 30 943 +/- 10,984 microm(2) that is higher than that observed in non-obese individuals. In 21% of the examined glomeruli, the glomerular planar surface area (GPSA) was >40,000 microm(2). Thickening of the glomerular basement membrane (GBM) and scattered paramesangial deposits were identified in 9 of 13 patients (70%) whose renal tissue was examined by electron microscopy. A reduction in the slit pore frequency was observed in obese patients due to extensive foot process effacement. Significant positive correlations between mean GPSA and body weight (r = 0.462, P = 0.05), and between GBM thickness and HbA1c, serum total cholesterol and triglyceride levels (r = 0.60, P = 0.05; r = 0.789, P = 0.004; r = 0.70, P = 0.016, respectively), were observed.
CONCLUSIONS: Glomerulomegaly as well as histological lesions resembling those of early diabetic nephropathy are observed in kidney biopsies of patients with morbid obesity even before the appearance of microalbuminuria. The potential regression of these changes after weight loss needs to be clarified.

Entities:  

Mesh:

Year:  2009        PMID: 19596742     DOI: 10.1093/ndt/gfp329

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  28 in total

1.  Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth.

Authors:  Bong Hee Park; Byong Chang Jeong; Seong Soo Jeon; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Hwang Gyun Jeon
Journal:  World J Urol       Date:  2015-04-03       Impact factor: 4.226

Review 2.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.

Authors:  Hisham E Elsherbiny; Mariam P Alexander; Walter K Kremers; Walter D Park; Emilio D Poggio; Mikel Prieto; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 4.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

5.  Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors.

Authors:  Andrew D Rule; Merfake H Semret; Hatem Amer; Lynn D Cornell; Sandra J Taler; John C Lieske; L Joseph Melton; Mark D Stegall; Stephen C Textor; Walter K Kremers; Lilach O Lerman
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

6.  Obesity Correlates With Glomerulomegaly But Is Not Associated With Kidney Dysfunction Early After Donation.

Authors:  Harini A Chakkera; Yu-Hui H Chang; Leslie F Thomas; Ramesh T Avula; Hatem Amer; Lilach O Lerman; Aleksandar Denic; Andrew D Rule
Journal:  Transplant Direct       Date:  2015-02-01

Review 7.  The role of obesity in kidney disease: recent findings and potential mechanisms.

Authors:  Rigas G Kalaitzidis; Kostas C Siamopoulos
Journal:  Int Urol Nephrol       Date:  2011-05-05       Impact factor: 2.370

8.  Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.

Authors:  Pongsathorn Gojaseni; Angkana Phaopha; Worawon Chailimpamontree; Thaweepong Pajareya; Anutra Chittinandana
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 9.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

10.  Mid-adulthood risk factor profiles for CKD.

Authors:  Gearoid M McMahon; Sarah R Preis; Shih-Jen Hwang; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.